GlassScriptPhysician profile
Patricia B Evans
NPI 1639461726
$3,114.82
in general payments reported to CMS, 2019-2025
14 companies · $941 in 2025
The $941 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $178 · 2022: $619 · 2023: $784 · 2024: $593 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,318.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,506.57 | 2021-2025 | Yeztugo, Biktarvy, Descovy |
| Viiv Healthcare Company | $964.75 | 2022-2025 | Dovato, Apretude, Cabenuva |
| Merck Sharp & Dohme LLC | $264.95 | 2023-2025 | Pifeltro, Delstrigo, Dificid |
| Abbvie INC. | $113.22 | 2023-2025 | |
| Exact Sciences Corporation | $58.62 | 2023-2025 | Cologuard Collection Kit |
| Organon LLC | $39.00 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $27.82 | 2023 | Prehevbrio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.64 | 2023 | Xifaxan |
| Theratechnologies INC. | $23.83 | 2021 | |
| Janssen Biotech, INC. | $20.90 | 2023 | Symtuza |
| Hartmann USA, INC. | $20.20 | 2025 | Zetuvit Plus 10x10 P10 |
| Amgen INC. | $19.33 | 2025 | Repatha |
| Pfizer INC. | $16.46 | 2024 | |
| Lilly USA, LLC | $14.53 | 2024 | Mounjaro, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.